Artelo Biosciences, Inc. Common Stock (ARTL) is a publicly traded Healthcare sector company. As of May 21, 2026, ARTL trades at $1.46 with a market cap of $3.19M and a P/E ratio of 0.00. ARTL moved +3.68% today. Year to date, ARTL is -63.59%; over the trailing twelve months it is -91.84%. Its 52-week range spans $1.25 to $85.80. Rallies surfaces ARTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Artelo Biosciences, Inc. Common Stock (ARTL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ARTL moved +3.68% today.
| Metric | Value |
|---|---|
| Price | $1.46 |
| Market Cap | $3.19M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $85.80 |
| 52-Week Low | $1.25 |
| Volume | 9.16K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-9.83M |
| Gross Margin | 0.00% |
ARTL analyst coverage data. Average price target: $0.00.